Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Practice Membership
Public Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to National Health Rsearch Institutes
Patents Assigned to National Health Rsearch Institutes
Pyrazole compounds and thiazole compounds as protein kinases inhibitors
Patent number:
9255072
Abstract:
A compound of formula (I): wherein A, B, D, X, Y, R1, R2, R3, m, p, and q are defined herein. Also disclosed is a method for inhibiting FMS-like tyrosine kinase 3, aurora kinase, or vascular endothelial growth factor receptor.
Type:
Grant
Filed:
March 1, 2012
Date of Patent:
February 9, 2016
Assignee:
National Health Rsearch Institutes
Inventors:
Weir-Torn Jiaang, Tsu-An Hsu, Wen-Hsing Lin, Yu-Sheng Chao